Taken together, our findings suggest that stage-dependent ILC2 activation might induce differential functioning of MDSCs through IL-13/IL-13Rα1 signaling during cancer progression from micro- to macrometastasis in breast cancer lung metastasis. This evidence concerns the gene IL13 and breast carcinoma.